Why the study?
The study was conducted to evaluate the survival impact of surgical resection among patients with pulmonary metastases from bone and soft tissue sarcomas.
Does pulmonary metastasectomy improve survival in patients with pulmonary metastases from bone and soft tissue sarcomas?
Population
34 consecutive patients with ≤5 pulmonary metastases from bone and soft tissue sarcomas
Comparison
Surgical treatment vs non-surgical treatment
Design
Retrospective study
Follow-up
Median 14.5 months
Authors
Loading...
Surgical resection may extend survival in selected patients; leaves open need for prospective trials to guide practice.
Does pulmonary metastasectomy improve survival in patients with pulmonary metastases from bone and soft tissue sarcomas?
Pulmonary metastasectomy is associated with significantly improved 3- and 5-year overall survival in patients with ≤5 pulmonary metastases from bone and soft tissue sarcomas, regardless of age.
Shimizu et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: